geraniol has been researched along with Hemolysis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdulmalek, S; Abu Alrub, H; El Azab, EF; Elfaki, EM; Hamza, A; Mazhari, BBZ; Saleh, AM; Yousif, SO | 1 |
| Khan, LA; Manzoor, N; Sharma, Y | 1 |
2 other study(ies) available for geraniol and Hemolysis
| Article | Year |
|---|---|
New insights into geraniol's antihemolytic, anti-inflammatory, antioxidant, and anticoagulant potentials using a combined biological and in silico screening strategy.
Topics: Acyclic Monoterpenes; Animals; Anti-Inflammatory Agents; Anticoagulants; Antioxidants; Chlorides; Diclofenac; Hemolysis; Humans; Inflammation; Interleukin-10; Interleukin-8; Lipopolysaccharides; Malondialdehyde; MAP Kinase Kinase Kinase 5; Molecular Docking Simulation; Nitric Oxide; Rats; Superoxide Dismutase; Thromboplastin; Tumor Necrosis Factor-alpha | 2022 |
Anti-Candida activity of geraniol involves disruption of cell membrane integrity and function.
Topics: Acyclic Monoterpenes; Antifungal Agents; Candida; Candidiasis; Cell Membrane; Dose-Response Relationship, Drug; Hemolysis; Humans; Microbial Sensitivity Tests; Permeability; Terpenes | 2016 |